NASDAQ:CSTL (Castle Biosciences, Inc.)

About CSTL

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
  • Castle Biosciences, Inc. (NASDAQ: CSTL) Latest News

    No posts found.